Victor McGaughey, APRN
Primary Care · Lecanto, FLNPI 1528812021
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $719 of the $828 with a category attached, or 86.8%. Medtronic accounts for 65.0% of it on its own, with 8 other manufacturers making up the rest.
Across 34 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$538
- Endo USA, Inc.$66
- Sumitomo Pharma America, Inc.$47
- Tolmar, Inc.$46
- Boston Scientific$38
- Procept Biorobotics Corporation$34
- plus $60 from 3 others
What the payments were for
- Travel & lodging$425%
- Food & beverage$71987%
- Education$688%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $538 |
| Endo USA, Inc. | 3 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Tolmar, Inc. | 2 | $46 |
| Boston Scientific | 1 | $38 |
| Procept Biorobotics Corporation | 1 | $34 |
| Johnson & Johnson | 1 | $21 |
| Merck | 1 | $20 |
| AbbVie | 1 | $19 |
How this compares
$828 in reported general payments places this provider in the 65th percentile of 725 primary care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $445 |
| Tamsulosin Hcl | 21 | $393 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 47 | $391 |
| Ciprofloxacin Hcl | 22 | $144 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $41 |
Paid to pharmacies, not to this prescriber.
Other primary care in Lecanto
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
- Robert PerriPalm Coast$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.